Faeth Therapeutics, Inc.

Direct answer

Faeth Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FTH.

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]

Can you invest in Faeth Therapeutics, Inc.?

Yes. Faeth Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FTH.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Faeth Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.